Raymond Dennis Pratt, VP of Drug Development at Rockwell Med, holds 310.00K shares in Savara (Ticker: SVRA), holds 353.36K shares in Rockwell Med (Ticker: RMTI).

See the Hottest Stocks Based on Insider Trading >

Raymond Dennis Pratt
Rockwell Med (RMTI)
VP of Drug Development

Ranked #10,378 out of 98,743 Corporate Insiders

Profitable Transactions

2 out of 3 Profitable Transactions

Average Return

+89.60%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

73.23%

SVRA

26.77%

RMTI

A breakdown of Raymond Dennis Pratt's holdings

See the Top Stocks by Insiders

Insider Roles

Savara
(SVRA)

CMO

Rockwell Med
(RMTI)

VP of Drug Development

Roles that Raymond Dennis Pratt holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Savara
(SVRA)

Rating:Informative Buy

Date:Dec 22, 2022 - Dec 22, 2023

Return:+235.60%

The most profitable trade made by Raymond Dennis Pratt

See the Latest Stocks Traded by Insiders

Raymond Dennis Pratt's Trading History

RMTI

Rockwell Med

Apr 27, 2020

VP of Drug Development

Uninformative Sell

10.47K

$565.37K

SVRA

Savara

Dec 18, 2023

CMO

Uninformative Buy

―

$1.55M

List of latest transactions for each holding click on a transaction to see Raymond Dennis Pratt's performance on stock

See All Insider Trading from Today

Raymond Dennis Pratt insider profile FAQ

What is the percentage of profitable transactions made by Raymond Dennis Pratt?

The percentage of profitable transactions made by Raymond Dennis Pratt is 67%.

What is the average return per transaction made by Raymond Dennis Pratt?

The average return per transaction made by Raymond Dennis Pratt is 89.60%.

What stocks does Raymond Dennis Pratt hold?

Raymond Dennis Pratt holds: RMTI, SVRA stocks.

What was Raymond Dennis Pratt’s latest transaction?

Raymond Dennis Pratt latest transaction was an Uninformative Buy of ―.

What was Raymond Dennis Pratt's most profitable transaction?

Raymond Dennis Pratt’s most profitable transaction was an Informative Buy of SVRA stock on December 22, 2022. The return on the trade was 235.60%.

What is Raymond Dennis Pratt's role in Rockwell Med?

Raymond Dennis Pratt's role in Rockwell Med is VP of Drug Development.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Raymond Dennis Pratt Insider Profile

Raymond Dennis Pratt Rockwell Med (RMTI)VP of Drug Development